We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Early Detection of Pseudomonas aeruginosa Increases Survival Chances

By Labmedica staff writers
Posted on 29 Jul 2008
A technique has been developed for the early detection of superbug Pseudomonas aeruginosa, which particularly infects patients with cystic fibrosis.

In the new diagnostic method, a non-colored compound reacts with an enzyme present in the bacteria and produces a very distinctive purple color. More...
The technique works on 99% of the strains P. aeruginosa.

The bacteria infect the fluid in the lungs of cystic fibrosis patients and also attack patients with localized and systemic immune defects, such as those suffering from burns, patients with AIDS, and cancer. P. aeruginosa accounts for 10% of all nosocomial infections, according to the Centers for Disease Control and Prevention in the United States (CDC; Atlanta, GA, USA).

The infections are difficult to treat because the bacteria are tolerant to many detergents, disinfectants, and antimicrobial compounds. They are especially difficult to control in hospitals and institutional environments and therefore hospital staff needs to diagnose the cause of the infections very quickly.

Researchers from the University of Sunderland (UK), the North Umbria University (Newcastle, UK), and bioMérieux, France
(Marcy l'Etoile) developed the technique that can identify Pseudomonas within 24-48 hours of infection, greatly increasing the patient's chances of survival.


Related Links:
Centers for Disease Control and Prevention in the United States
University of Sunderland
bioMérieux

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Automated Urinalysis Solution
UN-9000
Hematology Consumables
Bioblood Devices
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: 123RF

UK Project Advances Blood-Based Dementia Testing Toward Routine Clinical Care

Dementia is the leading cause of death in the UK, accounting for almost one in eight deaths, with more than 72,000 people dying from dementia, including Alzheimer’s disease, in 2025. Despite this burden,... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: TruVerus is designed to deliver a broad menu of routine blood tests from a small blood sample on a single, automated benchtop platform (Photo courtesy of Truvian Health)

Collaboration Advances Automated Benchtop Platform for Routine Blood Testing

Routine blood testing is central to clinical decision-making, but access can vary across laboratory and healthcare settings. Broader use of automated benchtop platforms may help integrate testing more... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.